Effects of Long-Term Combined Aerobic and Resistance Training According to MTHFR C677T Genotype in Patients with Chronic Stroke
Source abstract
Abstract
Elevated plasma homocysteine (tHcy) is a modifiable risk factor for stroke and cardiovascular disease, influenced by genetic and lifestyle factors. Resistance-based training may reduce tHcy, but the impact of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism remains unclear. This study examined the effects of a 26-week combined aerobic and resistance training program on stroke-related risk factors and tHcy levels in patients with chronic ischemic stroke, stratified by MTHFR genotype. Forty-six patients (mean age: 57.7 ± 8.9 years) completed supervised training three times per week. Assessments before and after the intervention included anthropometry, cardiorespiratory fitness, biochemical markers, and tHcy. Dietary intake was monitored and remained stable. Significant improvements were observed in body weight, fat mass, waist-to-hip ratio, VO2max, and 6 min walk distance. tHcy decreased significantly overall (p < 0.01), with reductions confined to the CC genotype group (p < 0.01). BMI declined in CC and CT groups (p < 0.01 and p < 0.05), while fat-free mass, triglycerides, fasting glucose, and blood pressure showed no changes, likely due to pharmacological control. These findings suggest that combined training improves body composition and functional capacity, while genotype-specific reductions in tHcy highlight the potential of personalized rehabilitation strategies integrating genetic and nutritional considerations in stroke care.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Stroke Rehabilitation and Recovery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Sports Rehabilitation, Doowon Technical University, 159, Jurawi-gil, Paju-eup, Paju-si 10838, Republic of Korea
Department of Prescription and Rehabilitation of Exercise, Dankook University, 119, Dandae-ro, Dongnam-gu, Cheonan-si 31116, Republic of Korea
References (49)
Show source-provided references
1. World Stroke Organization: Global Stroke Fact Sheet 202510.1177/17474930241308142 ↗
2. Stroke rehabilitation10.1016/S0140-6736(11)60325-5 ↗
3. Pinzon, R.T., Wijaya, V.O., and Veronica, V. (2023). The role of homocysteine levels as a risk factor of ischemic stroke events: A systematic review and meta-analysis. Front. Neurol., 14.10.3389/fneur.2023.1144584 ↗
4. Hyperhomocysteinemia and Ischemic Stroke: A Potential Dose-Response Association-A Systematic Review and Meta-analysis
5. Fan, R., Zhang, A., and Zhong, F. (2017). Association between Homocysteine Levels and All-cause Mortality: A Dose-Response Meta-Analysis of Prospective Studies. Sci. Rep., 7.10.1038/s41598-017-05205-3 ↗
6. Zarembska, E., Ślusarczyk, K., and Wrzosek, M. (2023). The Implication of a Polymorphism in the Methylenetetrahydrofolate Reductase Gene in Homocysteine Metabolism and Related Civilisation Diseases. Int. J. Mol. Sci., 25.10.3390/ijms25010193 ↗
7. Deminice, R., Ribeiro, D.F., and Frajacomo, F.T. (2016). The Effects of Acute Exercise and Exercise Training on Plasma Homocysteine: A Meta-Analysis. PLoS ONE, 11.10.1371/journal.pone.0151653 ↗
8. Exercise-induced changes in cardiovascular function after stroke: A randomized controlled trial10.1111/ijs.12156 ↗
9. Effects of exercise training on stroke risk factors, homocysteine concentration, and cognitive function according the APOE genotype in stroke patients10.12965/jer.1836108.054 ↗
10. VITATOPS Trial Study Group (2010). B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: A randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol., 9, 855–865.10.1016/S1474-4422(10)70187-3 ↗
11. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: The CSPPT randomized clinical trial10.1001/jama.2015.2274 ↗
12. B vitamins for stroke prevention10.1136/svn-2018-000156 ↗
13. Plasma homocysteine and menopausal status10.1111/j.1365-2362.1995.tb01687.x ↗
14. Age at natural menopause in Koreans: Secular trends and influences thereon
15. Executive summary of stroke statistics in Korea 2018: A report from the Korean Stroke Society and Clinical Research Center for Stroke10.5853/jos.2018.03125 ↗
16. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase10.1038/ng0595-111 ↗
17. Comparison between the six-minute walk test and the six-minute step test in post-stroke patients10.1186/1755-7682-6-31 ↗
18. Metabolic parameters for ramp versus step incremental cycle ergometer tests10.1139/h2012-098 ↗
19. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association10.1161/01.STR.32.1.280 ↗
20. Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity10.7570/jomes23031 ↗
21. Resistance training lowers exercise-induced oxidative stress and homocysteine levels in overweight and obese older adults10.1038/oby.2006.224 ↗
22. Lakens, D. (2013). Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs. Front. Psychol., 4.10.3389/fpsyg.2013.00863 ↗
23. Effect Size Guidelines for Individual and Group Differences in Physiotherapy
24. Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: The CardioRACE trial10.1093/eurheartj/ehad827 ↗
25. Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults10.1056/NEJMoa1616338 ↗
26. Abdominal obesity, body mass index, and hypertension in US adults: NHANES 2007–2010
27. Association between adiposity and cardiovascular outcomes: An umbrella review and meta-analysis of observational and Mendelian randomization studies10.1093/eurheartj/ehab454 ↗
28. Recurrent ischemic stroke–a systematic review and meta-analysis10.1016/j.jstrokecerebrovasdis.2021.105935 ↗
29. Community-dwelling people with chronic stroke need disproportionate attention while walking and negotiating obstacles10.1016/j.gaitpost.2012.02.002 ↗
30. Falls in individuals with stroke10.1682/JRRD.2007.09.0145 ↗
31. Walking-adaptability therapy after stroke: Results of a randomized controlled trial10.1186/s13063-021-05742-3 ↗
32. Distance-induced changes in walking speed after stroke: Relationship to community walking activity
33. Minimal clinically important difference of the 6-minute walk test in people with stroke10.1097/NPT.0000000000000236 ↗
34. Recovery of gait after stroke: What changes?10.1177/1545968308317972 ↗
35. Systematic Review and Meta-Analysis of Home-Based Rehabilitation on Improving Physical Function Among Home-Dwelling Patients with a Stroke10.1016/j.apmr.2019.10.181 ↗
36. Effect of aerobic training on vascular and metabolic risk factors for recurrent stroke: A meta-analysis10.1080/09638288.2019.1692251 ↗
37. Treadmill aerobic training improves glucose tolerance and indices of insulin sensitivity in disabled stroke survivors: A preliminary report10.1161/STROKEAHA.107.490391 ↗
38. Angiotensin-converting enzyme inhibitors in hypertension: To use or not to use?10.1016/j.jacc.2018.01.058 ↗
39. Beta-blockers for hypertension
40. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials10.1016/S0140-6736(10)61350-5 ↗
41. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: A randomized controlled trial10.1001/jama.2010.1710 ↗
42. Is Concurrent Training Efficacious Antihypertensive Therapy? A Meta-analysis10.1249/MSS.0000000000001056 ↗
43. Effects of Exercise on Vascular Function, Structure, and Health in Humans10.1101/cshperspect.a029819 ↗
44. Weight loss reduces C-reactive protein levels in obese postmenopausal women10.1161/hc0502.103331 ↗
45. Raghubeer, S., and Matsha, T.E. (2021). Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks. Nutrients, 13.10.3390/nu13124562 ↗
46. Detection of vitamin B12 deficiency in older people by measuring vitamin B12 or the active fraction of vitamin B12, holotranscobalamin10.1373/clinchem.2006.080382 ↗
47. Causes and early diagnosis of vitamin B12 deficiency
48. Effects of homocysteine lowering with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37,485 individuals10.1001/archinternmed.2010.348 ↗
49. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia10.1016/j.febslet.2006.04.088 ↗